compounded glp 1 risks New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compounding, Peptides, and GLP-1s: Opportunities
Description
Even if the price is right, can you count on the service
16 Instagram post
It is important to note that compounded semaglutide and compounded tirzepatide are not FDA-approved
That does not guarantee insurance approval, a prescription, weight loss, or the lowest advertised price
Survodutide (BI 456906) is similar to the active ingredient tirzepatide (Mounjaro, Zepbound) in that it combines two mechanisms of action
Who is a good candidate for GLP-1 pills
